Dr. Jerry Silver Research Fans

This is wonderful news!

I’m writing with some pretty great news: the Spinal Cord Injury Research Program (SCIRP) has just been restored to $33M in a Defense Appropriations Act that passed both the House and Senate and was ultimately signed by President Trump.

That means a majority of the funding for SCI research - which was completely cut from last year’s Department of Defense budget - has just been restored. While we didn’t get it back to $40 million, $33 million is a lot more than $0!
The bi-weekly meetings that we spearheaded and convened with other SCI organizations along with our continued outreach to federal legislators have helped Save SCIRP from elimination. The unity that you all have brought and the support you’ve given to this effort has made a real difference.

And - for the first time - spinal cord injury as a condition was newly added for consideration to the Peer Review Medical Research Program (PRMRP). This is a separate program within CDMRP which will allow SCI to be “absorbed” for funding if our stand alone program is ever cut in the future. The PRMRP was not previously an option for them and now exists as another avenue for funding. 

This win provides us with great momentum as we prepare to Roll on the Capital in just two weeks, during day three of our 20th Annual Science & Advocacy Symposium in Washington, D.C.. Consider registering so you can join us if you haven’t already done so.
Let’s keep fighting and raising our voice to restore and expand SCI research at the Federal level!

Link in bio‼️

Chicago’s WGN-TV interviews Dr. Brad Lang, NervGen Pharma CEO Dr. Adam Rogers and also one of the chronic trial subjects!

NVG-291 Profiled on WGN-TV! 🫶 Se alla dina favoriter bland videor och musik, ladda upp originalinnehåll och dela allt med vänner, familj och hela världen på YouTube.

NervGen Wings for Life Go NIKO! 💪
https://www.wingsforlife.com/uk/latest/nvg-291-a-new-hope

Larry Williams details how NVG-291 changed his life and details his recovery!
See: https://www.cbsnews.com/philadelphia/video/how-an-experimental-drug-is-helping-this-pennsylvania-man-recover-from-an-accident/?

📣📣📣 MORE BREAKING NEWS from NervGen Pharma!
See: https://www.stocktitan.net/news/NGENF/nerv-gen-pharma-s-nvg-291-r-demonstrates-significant-functional-11t8n2nkjtd3.html

NeurologyLive spotlights results from NervGen Pharma Corp’s chronic clinical
trial at Shirley Ryan AbilityLab!

Insights on NervGen Pharma’s Positive Phase 1b/2a Data for NVG-291 in Spinal Cord Injury Daniel Mikol, MD, PhD, chief medical officer at NervGen Pharma, provided clinical perspective on recently announced positive findings from a phase 1b/2a trial testing NVG-291 as a treatment for spinal cord injury.

Are you just now learning about the pioneering research of Dr. Jerry Silver, which led to the development of NVG-291 by NervGen Pharma Corp?
Here’s a video showing robust recovery in animal tests.

Rats before and after NVG-291, Nervgen Material is copied from Nervgen's origin story video. I edited it by slowing down the rats to .65 speed so we can see the rat limb movement more clearly. I...